Treatment de-intensification strategies for head and neck cancer

2016/10/15 by Jacqueline Kelly, Jacqueline R. Kelly, Zain Husain +2 · 1 citation
Medicine · #Cancer Diagnosis and Treatment #Esophageal Cancer Research and Treatment #Head and Neck Cancer Studies

paper · doi:10.1016/j.ejca.2016.09.006

openalex publication_date 2016/10/15 · crossref created 2016/10/15 · crossref issued 2016/11/01 · crossref published 2016/11/01 · crossref published-print 2016/11/01 · crossref deposited 2024/06/19 · openalex created_date 2025/10/10 · crossref indexed 2026/07/15 · openalex updated_date 2026/08/01

Citations

• Using Oracle Materialized Views
• Comprehensive genomic characterization of head and neck squamous cell carcinomas
• Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT?
• Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
• Squamous cell carcinoma of the oropharynx
• Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity
• Dose to the inferior pharyngeal constrictor predicts prolonged gastrostomy tube dependence with concurrent intensity-modulated radiation therapy and chemotherapy for locally-advanced head and neck cancer
• Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship
• Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
• Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
• Refining American Joint Committee on Cancer/Union for International Cancer Control TNM Stage and Prognostic Groups for Human Papillomavirus–Related Oropharyngeal Carcinomas
• Prognostic Significance of p16 INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
• Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant Metastasis
• Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
• Extracapsular spread in head and neck carcinoma: Impact of site and human papillomavirus status
• High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma
• Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma
• Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
• Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
• Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
• Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial
• Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
• The Epidemic of HPV-Associated Oropharyngeal Cancer Is Here: Is It Time to Change Our Treatment Paradigms?
• Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study

Cited by

• HPV-positive oropharyngeal cancer [wikipedia]